- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04164667
Telehealth Pilot for Veterans with Chronic Multi-Symptom Illness. (Telehealth)
Enhancing Executive Function and Self-regulation Success Through the Promotion of Brain Health Behaviors: a Telehealth Pilot Study for Veterans with Chronic Multi-symptom Illness.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington DC, District of Columbia, United States, 20422
- Washington DC Veteran's Affair Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Previously deployed Veterans
- Experiencing Chronic Multisymptom Illness defined using the Fukuda criteria.
- Able to engage in physical activity
- Has a smart phone
- Co-enrolled in the WRIISC Data Repository Study
Exclusion Criteria:
- Excessive alcohol consumption (AUDIT Score >= 4 (men); AUDIT Score >= 3 (women))
- Current or previous drug use past 90 days.
- Current prominent suicide or homicidal ideation
- Recent exposure to trauma
- Acute or unstable illness
- Dementia or significant cognitive impairments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Directed MAP (dMAP)
Participants received weekly text message directions from the ANNIE VA messaging system.
The directed text messaging system provided details on which app-based meditation and exercise sessions to complete.
|
In this study, the MAP intervention consisted of two MAP training sessions and one health coaching session per week for eight weeks. Both groups received the same MAP intervention with the exception of the delivery format (directed versus self-guided). Each MAP training session included 30 minutes of guided meditation and 30 minutes of moderate-to-vigorous aerobic exercise.
Other Names:
|
|
Active Comparator: Self-Guided MAP (sgMAP)
Participants received the intervention goals at the beginning of the study which included instruction on how to perform each of the individual components of the MAP protocol and how to use the study devices/apps, but they did not receive any further guidance during the intervention.
|
In this study, the MAP intervention consisted of two MAP training sessions and one health coaching session per week for eight weeks. Both groups received the same MAP intervention with the exception of the delivery format (directed versus self-guided). Each MAP training session included 30 minutes of guided meditation and 30 minutes of moderate-to-vigorous aerobic exercise.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility (Recruitment rate)
Time Frame: Through study completion, an average of 6 months
|
Recruitment rate was calculated as the number of participants who consented into the study divided by the number of eligible WRIISC patients who were approached during enrollment.
|
Through study completion, an average of 6 months
|
|
Feasibility (Retention rate)
Time Frame: Through study completion, an average of 6 months
|
Retention rate was calculated for each time point (endpoint and 3m follow-up) and reported as a percentage.
|
Through study completion, an average of 6 months
|
|
Feasibility (Adherence rate)
Time Frame: Through study completion, an average of 6 months
|
Due to the multiple components of the intervention, adherence rates were calculated for the meditation and exercise components separately and overall adherence to the MAP training protocol.
|
Through study completion, an average of 6 months
|
|
Safety of administering a telehealth MAP intervention
Time Frame: Through study completion, an average of 6 months
|
Number of adverse events reported during the intervention
|
Through study completion, an average of 6 months
|
|
Acceptability
Time Frame: Through study completion, an average of 6 months
|
Acceptability was quantified using the qualitative feedback provided by participants during their health coaching sessions.
|
Through study completion, an average of 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
The BRIEF-A was used to assess executive function across nine overlapping domains: Emotional Control, Initiate, Inhibit, Organization of Materials, Plan/Organize, Self-Monitor, Shift, Task Monitor, and Working Memory.
In addition, the Global Executive Composite score and two summary index scores (Behavioral Regulation Index and Metacognition Index) were calculated.
Higher scores are indicative of greater difficulty.
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Patient Health Questionnaire- Depression scale (PHQ-9)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
The PHQ-9 was used to assess the severity of depression symptoms.
Higher scores are indicative of greater depression symptoms.
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Posttraumatic Symptom Checklist - Military version (PCL-M)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
To evaluate the severity of PTSD symptoms in an individual who has had military experience.
Higher scores are indicative of greater PTSD symptoms.
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Perceived Stress Scale (PSS)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
To measure the perception of stress
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Brief Symptom Inventory (BSI)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
To evaluate the degree of psychological distress.
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Five-Factor Mindfulness Questionnaire (FFMQ)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
To evaluate mindfulness across five domains: Awareness, Describing, Non-judging of Inner Experience, Non-reactivity to Inner Experience, and Observing.
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Medical Outcomes Study Short-Form-36 version 2 (SF-36v2)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
To assess quality of life (physical and mental).
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Cognitive Difficulties Scale (CDS)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
To assess cognitive complaints.
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Baseline to Endpoint (2 months) and baseline to 5 months.
|
To measure the quality and patterns of sleep in adults.
Higher scores are indicative of sleep disturbance.
|
Baseline to Endpoint (2 months) and baseline to 5 months.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Matthew Reinhard, PsyD, DC WRIISC Director
- Principal Investigator: Michelle Costanzo, PhD, DC WRIIISC Research Director
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 01880
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Multisymptom Illness
-
Bronx Veterans Medical Research Foundation, IncU.S. Army Medical Research and Development CommandCompletedChronic Multisymptom Illness in Gulf War VeteransUnited States
-
Bronx Veterans Medical Research Foundation, IncBoston University; VA Boston Healthcare SystemUnknownChronic Multisymptom Illness in Gulf War VeteransUnited States
-
University of California, San DiegoNot yet recruitingToxicant Induced Chronic Multisymptom Illness and Associated Symptoms and ComorbiditiesUnited States
-
VA Office of Research and DevelopmentCompletedPain Predominant Chronic Multisymptom IllnessUnited States
-
National Institutes of Health Clinical Center (CC)CompletedSevere Chronic IllnessUnited States
-
Aydin Adnan Menderes UniversityCompletedCaregiver Stress in Chronic Mental Illness | Psychosocial Burden in Psychiatric Caregivers | Chronic Mental Illness Caregiving | Cognitive and Emotional Outcomes in Caregivers | Mental Illness Caregiver SupportTurkey (Türkiye)
-
University of OsloSykehuset Innlandet HF; Lovisenberg Diakonale HospitalCompletedSiblings of Children With Chronic IllnessNorway
-
Palo Alto Veterans Institute for ResearchUnited States Department of DefenseCompletedChronic Pain | Gulf War Illness | Chronic IllnessUnited States
-
VA Office of Research and DevelopmentCompleted
-
MedImmune LLCCompletedHealthy or Stable Chronic IllnessUnited States
Clinical Trials on Mental and physical (MAP) training intervention
-
Universiti Tunku Abdul RahmanCompleted
-
Instituto Nacional de Ciencias Medicas y Nutricion...Recruiting
-
Centre Hospitalier Universitaire DijonCompletedCorticospinal Plasticity | Neuromuscular PlasticityFrance
-
The Hong Kong Polytechnic UniversityUniversity of Santo TomasUnknownMild Cognitive ImpairmentPhilippines
-
Cairo UniversityRecruitingSpastic Diplegia | Motor ImageryEgypt
-
University of Nove de JulhoUniversity of Sao PauloCompleted
-
New York State Psychiatric InstituteCompletedElectroconvulsive Therapy | Memory DeficitsUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH); Wayne State University; University... and other collaboratorsCompletedOfficers' Skills and BehaviorsUnited States
-
Paracelsus Medical UniversityCompletedType 2 Diabetes MellitusAustria
-
Universidade Federal do Rio Grande do NorteUnknownRehabilitation | Gait Disorders, Neurologic | Kinematics | Primary ParkinsonismBrazil